Damian Reid

Experience

• 

  Arthur Andersen & Co.

  Sept 1984 - Apr 1988

  Audit Senior

  Qualified as Associate of the Institute of Chartered Accountants (ACA) in 1988. Latest position: Audit senior

• 

  S. G. Warburg (subsequently UBS)

  Jun 1988 - Feb 1998

  Executive Director

  Executive in the Corporate Finance Division of Warburg. Involved in execution of more than 25 transactions worth in aggregate more than US$10 billion. Generalist investment banker until 1993; member of the financial institutions group of Warburg until 1998. Latest position: Executive Director

• 

  The GEC plc (subsequently Marconi plc)

  Mar 1998 - Oct 2004

  Chief Strategy Officer

  Senior Vice President of Corporate Finance for GEC and then Marconi until 2001 responsible for more than 15 major acquisitions and disposals worth in aggregate over £15 billion; subsequently Chief Strategy Officer of Marconi during its successful financial restructuring, turnaround and re-listing on the London Stock Exchange.

• 

  France Telecom

  Nov 2004 - Oct 2007

  Executive Vice President, Strategy and Planning

  Responsible for preparation of business and financial plan for the group in 2007. Previously responsible for strategy, regulation, spectrum management, revenue assurance and fraud, insurance and sourcing at Orange Group from 2004 to 2006

• 

  Augere Group

  Nov 2007 - Jan 2015

  Chief Financial Officer

  CFO and one of the founders of Augere; group built from scratch to around 200,000 broadband customers with a wireless network of more than 800 radio base stations and approx. 500 employees in Bangladesh, Pakistan and India

• 

  Pro Bono Bio (subsequently Ascension Healthcare)

  Feb 2015 - Dec 2017

  Chief Financial Officer

  Pro Bono Bio is an international healthcare company that has developed a range of medical devices using nanotechnology. It has commercialized its technology to provide safe and effective healthcare products which also reduce the negative impacts of drugs. Pro Bono Bio uses its innovative technology to develop and sell topical gels under the ‘Flexiseq’ brand for the treatment of joint pain and muscle soreness. Sales are mainly in the UK and the EU. Market disruptive treatments for haemophiliacs are under development. Show less

• 

  BULK POWDERS®

  Jun 2018 - May 2020

  Finance Director

  Interim Finance Director, reporting to the board and owners of Bulk Powders, a rapidly growing sports nutrition business selling a wide range of products primarily over its own e-commerce platform direct to consumers throughout the UK and the EU.

• 

  Upp

  Dec 2020 - Oct 2023

  Chief Financial Officer

  CFO and one of the founders of Upp, a rapidly expanding provider of ultrafast broadband services over its own fibre to the premises network based in the East of England.From launch in January 2021, Upp connected its first customer within 9 months. By the end of September 2023, Upp's full fibre network had passed 150,000 premises in 21 towns and served almost 5,000 customers with an Excellent (4.9) TrustPilot score. Upp had around 180 employees by the end of Q3 2023.Upp was sold to Virgin Media O2 in September 2023 following an order from the UK government under the National Security and Investment Act for Upp's shareholder, LetterOne, to sell the business because of concerns about its Russian owners. Show less